# Interparfums Inc: overview

IPAR · Nasdaq · CIK 822663 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ipar.md) · [Financials](/companies/ipar/financials.md) · [Filings](/companies/ipar/filings.md) · [Insiders](/companies/ipar/insiders.md)

Latest reported revenue: [$341.0m](/filings/0001753926-26-001317.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001753926-26-001317).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [425](/filings/0001753926-25-001703.md) | [362 d](/filings/0001753926-26-000464.md) | [339](/filings/0001753926-26-000771.md) | [334](/filings/0001753926-26-001317.md) | [430](/filings/0001753926-25-001703.md) | [386 d](/filings/0001753926-26-000464.md) | [345](/filings/0001753926-26-000771.md) | [341](/filings/0001753926-26-001317.md) |
| Gross margin | % | [63.9%](/filings/0001753926-25-001703.md) | [64.5% d](/filings/0001753926-26-000464.md) | [63.7%](/filings/0001753926-26-000771.md) | [66.2%](/filings/0001753926-26-001317.md) | [63.5%](/filings/0001753926-25-001703.md) | [61.5% d](/filings/0001753926-26-000464.md) | [65.1%](/filings/0001753926-26-000771.md) | [65.5%](/filings/0001753926-26-001317.md) |
| Operating margin | % | [25.0%](/filings/0001753926-25-001703.md) | [10.0% d](/filings/0001753926-26-000464.md) | [22.2%](/filings/0001753926-26-000771.md) | [17.7%](/filings/0001753926-26-001317.md) | [25.3%](/filings/0001753926-25-001703.md) | [7.1% d](/filings/0001753926-26-000464.md) | [21.5%](/filings/0001753926-26-000771.md) | [14.4%](/filings/0001753926-26-001317.md) |
| Net margin | % | [14.7%](/filings/0001753926-25-001703.md) | [6.7% d](/filings/0001753926-26-000464.md) | [12.5%](/filings/0001753926-26-000771.md) | [9.6%](/filings/0001753926-26-001317.md) | [15.3%](/filings/0001753926-25-001703.md) | [7.3% d](/filings/0001753926-26-000464.md) | [12.6%](/filings/0001753926-26-000771.md) | [8.9%](/filings/0001753926-26-001317.md) |
| Diluted EPS | $ per share | [1.93](/filings/0001753926-25-001703.md) | not reported | [1.32](/filings/0001753926-26-000771.md) | [0.99](/filings/0001753926-26-001317.md) | [2.05](/filings/0001753926-25-001703.md) | not reported | [1.35](/filings/0001753926-26-000771.md) | [0.95](/filings/0001753926-26-001317.md) |
| Free cash flow | $m | [75.4 d](/filings/0001753926-25-001703.md) | [136 d](/filings/0001753926-26-000464.md) | [(8.8)](/filings/0001753926-26-000771.md) | [(3.3) d](/filings/0001753926-26-001317.md) | [57.6 d](/filings/0001753926-25-001703.md) | [145 d](/filings/0001753926-26-000464.md) | [(1.3)](/filings/0001753926-26-000771.md) | [44.6 d](/filings/0001753926-26-001317.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [880](/filings/0001753926-24-000405.md) | [1,087](/filings/0001753926-24-000405.md) | [1,318](/filings/0001753926-24-000405.md) | [1,452](/filings/0001753926-26-000464.md) | [1,489](/filings/0001753926-26-000464.md) |
| Gross margin | % | [63.3%](/filings/0001753926-24-000405.md) | [63.9%](/filings/0001753926-25-000424.md) | [63.7%](/filings/0001753926-26-000464.md) | [63.9%](/filings/0001753926-26-000464.md) | [63.6%](/filings/0001753926-26-000464.md) |
| Operating margin | % | [16.8%](/filings/0001753926-24-000405.md) | [17.9%](/filings/0001753926-25-000424.md) | [19.1%](/filings/0001753926-26-000464.md) | [18.9%](/filings/0001753926-26-000464.md) | [18.2%](/filings/0001753926-26-000464.md) |
| Net margin | % | [9.9%](/filings/0001753926-24-000405.md) | [11.1%](/filings/0001753926-25-000424.md) | [11.6%](/filings/0001753926-26-000464.md) | [11.3%](/filings/0001753926-26-000464.md) | [11.3%](/filings/0001753926-26-000464.md) |
| Diluted EPS | $ per share | [2.75](/filings/0001753926-24-000405.md) | [3.78](/filings/0001753926-25-000424.md) | [4.75](/filings/0001753926-26-000464.md) | [5.12](/filings/0001753926-26-000464.md) | [5.24](/filings/0001753926-26-000464.md) |
| Free cash flow | $m | [(21.7)](/filings/0001753926-24-000405.md) | [39.3](/filings/0001753926-25-000424.md) | [99.3](/filings/0001753926-26-000464.md) | [183](/filings/0001753926-26-000464.md) | [190](/filings/0001753926-26-000464.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ipar/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $326.3m | 2,916,610 |  | Added +182,195 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $149.0m | 1,332,120 |  | Added +17,955 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $146.1m | 1,305,673 |  | Added +40,283 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $115.9m | 1,036,004 |  | Added +156,999 |
| [WESTWOOD HOLDINGS GROUP INC](/funds/1165002.md) | 2026-06-30 | $99.1m | 886,100 |  | Reduced −119,494 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $96.9m | 866,595 |  | Added +70,406 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $96.7m | 864,092 |  | Added +41,132 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $89.2m | 797,275 |  | Added +8,954 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $83.6m | 747,627 |  | Added +39,329 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $80.2m | 716,526 |  | Added +74,792 |

## Recent filings

[All 1,098 filings](/companies/ipar/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:25 ET | [8-K](/filings/0001753926-26-001970.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001970 |
| 2026-09-22 | 20:32 ET | [8-K](/filings/0001753926-26-001849.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001849 |
| 2026-09-17 | 20:31 ET | [8-K](/filings/0001753926-26-001830.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001830 |
| 2026-09-16 | 15:37 ET | [8-K](/filings/0001753926-26-001798.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001798 |
| 2026-08-04 | 20:30 ET | [8-K](/filings/0001753926-26-001319.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001319 |
| 2026-08-04 | 20:23 ET | [10-Q](/filings/0001753926-26-001317.md) | Quarterly report, period 2026-06-30 | 0001753926-26-001317 |
| 2026-07-31 | 20:09 ET | [DEF 14A](/filings/0001753926-26-001295.md) | Proxy statement, period 2025-12-31 | 0001753926-26-001295 |
| 2026-07-22 | 20:27 ET | [8-K](/filings/0001753926-26-001221.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001221 |
| 2026-05-13 | 21:21 ET | [8-K](/filings/0001753926-26-000860.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001753926-26-000860 |
| 2026-05-05 | 20:43 ET | [8-K](/filings/0001753926-26-000773.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-000773 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001753926-26-000464.md), filed Mar 10, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 822663
- Tickers: IPAR
- Exchange: Nasdaq
- SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.